TMDX rides OCS adoption and strong fourth-quarter results, but margin pressure raises questions for investors.

Is TMDX a good stock to buy? We came across a bullish thesis on TransMedics Group, Inc. on The Cash Flow Compounder’s ...

Innovations often (but not always) drive life-changing returns for the companies that engineer them and the people who get in on the ground floor. That's why investors should sometimes look toward ...

ANDOVER, Mass., Feb. 9, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...

Read full article: Navigating HPV vaccine hesitancy: A doctor debunks myths, encourages cancer prevention Dr. Kyle Miletic, surgeon, talks about the procedure with heart transplant recipient Ken ...

Earlier in 2026, TransMedics Group outlined its expansion beyond organ care devices into a vertically integrated National OCS Program that now manages nearly 30% of U.S. transplant procedures, while ...

TransMedics remains the top dog in its industry and may have a widening moat. The founder-led company's shares have risen eightfold since 2019. TransMedics is consistently considered "overvalued," but ...

These healthcare growth stocks are profitable and revenue is growing at a double-digit pace. Intuitive Surgical is the top global player in the field of robotic surgery. TransMedics Group is ...